文献速递消化系统肿瘤

肿瘤内微生物群能否成为解锁肝细胞癌治疗反应的关键?

Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
PubMed 文献 · Eur J Cancer · 2024-12-21

本文为综述,探讨肝细胞癌(HCC)中肿瘤内微生物群的建立、对肿瘤发生的影响及其调控如何改善当前治疗。文章重点介绍HCC肿瘤中发现的关键细菌及其对肿瘤免疫微环境和肿瘤发生的作用,并探讨靶向肿瘤内微生物群的现有疗法,希望推动未来研究验证其作为改善HCC治疗反应的途径。

要点

  • 肠道微生物群已被广泛研究,证据显示肠道调节可能影响HCC的肿瘤发生和预后。
  • 近期文献提示肿瘤内微生物群可能对包括HCC在内的实体瘤发展产生显著影响。
  • 综述聚焦HCC肿瘤中发现的关键细菌及其对肿瘤免疫微环境和肿瘤发生的影响。

核心结论

  • 更深入理解肿瘤内微生物群如何建立、不同细菌如何参与HCC肿瘤发生及如何被靶向,有望推动未来研究验证其作为改善HCC治疗反应的途径。

研究设计与样本

  • 本文为综述,通过类比肠道与肝脏/肿瘤微生物群,探讨肝脏微生物群的建立、对肿瘤发生的影响及调控肠道和肝脏微生物群改善HCC当前治疗的可能性。

主要发现

  • 肠道微生物群已被广泛研究,证据显示肠道调节可能调节肿瘤发生和预后。
  • 近期文献提示存在肿瘤内微生物群,可能对包括HCC在内的实体瘤发展产生显著影响。
  • 综述重点介绍了HCC肿瘤中发现的关键细菌及其对肿瘤免疫微环境和HCC肿瘤发生的可能影响。
  • 综述探讨了当前靶向肿瘤内微生物群的疗法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocellular carcinoma (HCC) is the third cause of cancer-related mortality worldwide. Current treatments include surgery and immunotherapy with variable response. Despite aggressive treatment, disease progression remains the biggest contributor to mortality. Thus, there is an urgent unmet need to improve current treatments through a better understanding of HCC tumourigenesis. The gut microbiota has been intensively examined in the context of HCC, with evidence showing gut modulation has the potential to modulate tumourigenesis and prognosis. In addition, recent literature suggests the presence of an intratumoural microbiota that may exert significant impacts on the development of solid tumours including HCC. By drawing parallels between the gut and hepatic/tumoural microbiota, we explore in the present review how the hepatic microbiota is established, its impact on tumourigenesis, and how modulation of the gut and hepatic microbiota may be key to improving current treatments of HCC. In particular, we highlight key bacteria that have been discovered in HCC tumours, and how they may affect the tumour immune microenvironment and HCC tumourigenesis. We then explore current therapies that target the intratumoural microbiota. With a deeper understanding of how the intratumoural microbiota is established, how different bacteria may be involved in HCC tumourigenesis, and how they can be targeted, we hope to spark future research in validating intratumoural microbiota as an avenue for improving treatment responses in HCC.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Yu KL, Shen S. Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma? Eur J Cancer. 2024. PMID: 39729679. doi:10.1016/j.ejca.2024.115195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。